About Dr. Krishna Kodukula

Dr. Kodukula is the Executive Director of CADRE (The Center for Advanced Drug Research) at SRI-Shenandoah Valley, of SRI-Biosciences.

Dr. Kodukula brings exceptional skills to SRI from his long tenure in the pharmaceutical and biotechnology industries. While at Sarnoff, an SRI subsidiary, he was the technical lead for a national program to develop technologies and strategies for reducing the drug discovery and development time during a national emergency.

Prior to working at Sarnoff, Dr. Kodukula helped launch Small Molecule Therapeutics, a drug discovery start-up in the Princeton area, and co-found Pyxis Technology Solutions, an IT tools developer, based in India and in the U.S. Previously, he was a senior research investigator at Bristol-Myers Squibb Pharmaceutical Research Institute and a fellow at the Roche Institute of Molecular Biology, Hoffman-La Roche. Dr. Kodukula has a Ph.D. in biochemistry and botany from Utkal University, Bhubaneswar in India. He did postdoctoral work at the Indian Institute of Science, where he was a National Biotechnology Board Fellow. He is an author of many publications and several patent applications. Dr. Kodukula is a member of the American Society for Biochemistry and Molecular Biology, and the Society for Biomolecular Sciences. He is also a member of the NIAID/NIH special panel on research and development for biodefense applications, and has served on review committees since 2004.

Source: SRI Press Release, 2006.